drugset / Trial / NCT01822977
The Impact of Proton Pump Inhibitors on the Fecal Microbiome
NaSingle-groupOpen-label
Summary
The investigators hypothesis is that daily use of a proton pump inhibitor (PPI) is associated with significant alterations in the healthy fecal microbiome that are similar to those seen in persons with an initial episode of clostridium difficile infection (CDI).
Timeline
- Start
- 2013-03
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Omeprazole | Other / unclassified | 20 mg | — |